• 1171 Citations
  • 18 h-Index
20002018
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Vittorio Maglione is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 1 Similar Profiles
Huntington Disease Medicine & Life Sciences
Mutation Medicine & Life Sciences
Neurodegenerative Diseases Medicine & Life Sciences
Central Nervous System Cavernous Hemangioma Medicine & Life Sciences
Age of Onset Medicine & Life Sciences
Corpus Callosum Medicine & Life Sciences
Neurodegenerative diseases Chemical Compounds
Corpus Striatum Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2000 2018

  • 1171 Citations
  • 18 h-Index
  • 39 Article
  • 3 Review article
  • 2 Comment/debate
1 Citation (Scopus)

Correction: Defective Sphingosine-1-phosphate metabolism is a druggable target in Huntington's disease (Scientific Reports DOI: 10.1038/s41598-017-05709-y)

Di Pardo, A., Amico, E., Basit, A., Armirotti, A., Joshi, P., Neely, M. D., Vuono, R., Castaldo, S., Digilio, A. F., Scalabrì, F., Pepe, G., Elifani, F., Madonna, M., Jeong, S. K., Park, B. M., D'Esposito, M., Bowman, A. B., Barker, R. A. & Maglione, V., Dec 1 2018, In : Scientific Reports. 8, 1, 8266.

Research output: Contribution to journalComment/debate

Huntington Disease
sphingosine 1-phosphate

New Therapeutic Drugs from Bioactive Natural Molecules: The Role of Gut Microbiota Metabolism in Neurodegenerative Diseases

Di Meo, F., Donato, S., Di Pardo, A., Maglione, V., Filosa, S. & Crispi, S., 2018, In : Current Drug Metabolism. 19, 6, p. 478-489 12 p.

Research output: Contribution to journalReview article

Neurodegenerative diseases
Metabolism
Neurodegenerative Diseases
Brain
Molecules

Sphingolipid Metabolism: A New Therapeutic Opportunity for Brain Degenerative Disorders

Di Pardo, A. & Maglione, V., Apr 17 2018, In : Frontiers in Neuroscience. 12, p. 249

Research output: Contribution to journalReview article

Sphingolipids
Brain Diseases
Neurodegenerative Diseases
Therapeutics
Clinical Trials
7 Citations (Scopus)

Stimulation of S1PR5 with A-971432, a selective agonist, preserves blood-brain barrier integrity and exerts therapeutic effect in an animal model of Huntington's disease

Di Pardo, A., Castaldo, S., Amico, E., Pepe, G., Marracino, F., Capocci, L., Giovannelli, A., Madonna, M., van Bergeijk, J., Buttari, F., van der Kam, E. & Maglione, V., Jul 15 2018, In : Human Molecular Genetics. 27, 14, p. 2490-2501 12 p.

Research output: Contribution to journalArticle

Huntington Disease
Therapeutic Uses
Blood-Brain Barrier
Lysosphingolipid Receptors
Animal Models
6 Citations (Scopus)

The S1P Axis: New Exciting Route for Treating Huntington's Disease

Di Pardo, A. & Maglione, V., May 1 2018, In : Trends in Pharmacological Sciences. 39, 5, p. 468-480 13 p.

Research output: Contribution to journalReview article

Huntington Disease
Brain
Brain Diseases
Drug Delivery Systems
Neurodegenerative Diseases